Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Sensorineural Hearing Loss: early-phase trial registry
6 of 14 indexed Sensorineural Hearing Loss trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 6 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Sensorineural Hearing Loss: 14 US clinical trials tracked, 6 recruiting.
Sensorineural Hearing Loss is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Cochlear, running 5 of these trials.
Enrollment posture brief
Registry condition sensorineural-hearing-loss
OPEN 6 | RECR 43% | LATE 0 | EARLY 2 | RANK #1230 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Acute Myelogenous Leukemia (AML) (43% recruiting · 7 trials)
Sensorineural Hearing Loss lists 6 open slots (43% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Sensorineural Hearing Loss on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Sensorineural Hearing Loss is recruiting below its size-band peers.
6 of 14 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Sensorineural Hearing Loss research.
Cochlear accounts for 5 of 14 trials (35.7%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Sensorineural Hearing Loss trials plan to enrol fewer than 100 people.
Median target enrolment is 52 among the 14 trials that report a genuine target (sentinel values excluded). 10 of those (71.4%) plan for fewer than 100 participants.
-
Sensorineural Hearing Loss research is mostly interventional.
11 interventional and 3 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
Long-Term Outcomes of Children With Congenital CMV in New York State
Stony Brook University
NCT06226558
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
University of Southern California
NCT05634356
Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
Dartmouth-Hitchcock Medical Center
NCT05107466
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
University of Utah
NCT06053190
Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
NYU Langone Health
NCT07039435
Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
Cochlear
NCT06936449
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
Envoy Medical Corporation
NCT06699797
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
Albert Park
NCT03107871
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
Otonomy
NCT04129775
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
Cochlear
NCT00678899
Cochlear Implant With Dexamethasone Eluting Electrode Array
Cochlear
NCT04750642
The Effect of Sound Stimulation on Pure-tone Hearing Threshold
Earlogic Korea
NCT01184248
Fundamental Asynchronous Stimulus Timing Sound Coding Study
Cochlear
NCT02698787
Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing
Cochlear
NCT04741009
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Sensorineural Hearing Loss records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Sensorineural Hearing Loss trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Sensorineural Hearing Loss page
14 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Sensorineural Hearing Loss trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cochlear sponsors the most Sensorineural Hearing Loss trials on record, review their full trial history before evaluating a specific study. See Cochlear's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sensorineural Hearing Loss condition card totals 14 registered trials; most-linked intervention CI632; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.